Literature DB >> 2223062

Sialophorin (CD43) and the Wiskott-Aldrich syndrome.

E Remold-O'Donnell1, F S Rosen.   

Abstract

Wiskott-Aldrich syndrome is an inherited deficiency of T-lymphocyte function and of platelets. The observation in 1981-84 of deficiency and/or defects in Wiskott-Aldrich lymphocytes of the surface molecule sialophorin (CD43) spurred intensive study of this molecule. Sialophorin (CD43) is now known to be a prevalent molecule on most circulating blood cells; it is a transmembrane molecule subject to phosphorylation reactions and capable of intracellular signaling. Oligosaccharides constitute 60% of the molecule. The extracellular region resembles acidic mucin molecules with expanded structure and dense negative charge. The sialophorin (CD43) polypeptide is subject to alternative glycosylation pathways that are cell-specific. CD43 functions in vitro as the receptor of an independent pathway of T-lymphocyte and monocyte activation. CD43 is hypothesized to regulate the survival of blood cells in the circulation. This review covers the distribution, chemistry, cDNA cloning, genetic analysis and functional analysis of CD43, and summarizes recent findings of related defects in Wiskott-Aldrich lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2223062

Source DB:  PubMed          Journal:  Immunodefic Rev        ISSN: 0893-5300


  17 in total

Review 1.  CD43, a molecule with multiple functions.

Authors:  Y Rosenstein; A Santana; G Pedraza-Alva
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  CD43 gene expression is mediated by a nuclear factor which binds pyrimidine-rich single-stranded DNA.

Authors:  O C Farokhzad; J M Teodoridis; H Park; M A Arnaout; C S Shelley
Journal:  Nucleic Acids Res       Date:  2000-06-01       Impact factor: 16.971

3.  Induction of neutrophil homotypic adhesion via sialophorin (CD43), a surface sialoglycoprotein restricted to haemopoietic cells.

Authors:  A R Rosenkranz; O Majdic; J Stöckl; W Pickl; H Stockinger; W Knapp
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

4.  CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes.

Authors:  V Bazil; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

5.  CD43-mediated IFN-γ production by CD8+ T cells promotes abdominal aortic aneurysm in mice.

Authors:  Hui-fang Zhou; Huimin Yan; Judy L Cannon; Luke E Springer; Jonathan M Green; Christine T N Pham
Journal:  J Immunol       Date:  2013-04-12       Impact factor: 5.422

6.  Studies of the expression of the Wiskott-Aldrich syndrome protein.

Authors:  D M Stewart; S Treiber-Held; C C Kurman; F Facchetti; L D Notarangelo; D L Nelson
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

7.  Wiskott-Aldrich syndrome carrier detection with the hypervariable marker M27 beta.

Authors:  G de Saint Basile; L D Notarangelo; C Bonaiti-Pellié; M Doussau; O Prolini; I W Craig; A Ugazio; C Griscelli; A Fischer
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

8.  Protective role of sialophorin (CD43)-expressing cells in experimental Staphylococcus aureus infection.

Authors:  T Bremell; R Holmdahl; A Tarkowski
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  Defective B-cell and regulatory T-cell function in Wiskott-Aldrich syndrome.

Authors:  Y L Lau; B M Jones; L C Low; S N Wong; N K Leung
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

10.  Amino acid sequence of human plasma galactoglycoprotein: identity with the extracellular region of CD43 (sialophorin).

Authors:  K Schmid; M A Hediger; R Brossmer; J H Collins; H Haupt; T Marti; G D Offner; J Schaller; K Takagaki; M T Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.